Navigation Links
Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
Date:2/5/2009

MELBOURNE, Australia, Feb.5 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has successfully concluded dose-escalation in its oral Phase I study for CYT997, the company's anticancer vascular-disrupting agent (VDA).

The primary objectives of this safety and tolerability study have been achieved. These were to determine the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) for the agent when administered orally in capsule form every two weeks to patients with a diverse range of solid tumors. Safety and tolerability data from this study augments data obtained in the company's first Phase I study where CYT997 was administered intravenously. Together, these studies suggest that the CYT997 is a potent and selective VDA which is well tolerated at biologically efficacious doses and is worthy of further investigation as a novel anticancer agent.

"Cytopia has now demonstrated the broad clinical potential of CYT997 in both intravenous and oral forms," said Mr. Andrew Macdonald, CEO. "The oral activity of CYT997 is a key advantage over most other vascular disrupting agents which are administered intravenously. The oral activity of the agent should markedly improve its clinical and commercial value."

The company has already commenced Phase II studies for the intravenous form of CYT997 and intends to undertake similar efficacy studies for the oral presentation. Investigating the safety and efficacy of metronomic dosing, frequent oral administration at a comparatively low, but biologically effective dose, is of particular interest.

This oral trial was partly funded under the company's $A3 million Commercial Ready grant.

Preliminary trial data

CYT997 was generally well tolerated in this study with a maximum tolerated dose in cancer patients of ca 165 mg/m2. This dose resulted in maximal plasma concentrations some twofold higher than those obse
'/>"/>

SOURCE Cytopia Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cytopia Scientific Presentations on JAK2 Inhibitor Program
2. Cytopia Commences Second Phase II Study in Brain Cancer
3. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
4. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
5. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
6. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
7. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
8. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
9. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
10. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
11. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)...  New guidelines released today by the American ... for better outcomes to the hundreds of thousands ... each year. Stryker,s Trevo ® Retriever was ... clinical trials that provided data for this development. ... endovascular therapy with stent retrievers for ischemic stroke ...
(Date:6/29/2015)... 29, 2015  Allergan plc (NYSE: AGN ... second quarter 2015 financial results on Thursday, August ... U.S. financial markets. The Company will host a conference ... Time on Thursday, August 6, 2015 to discuss ... call is U.S./ Canada (877) ...
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2
... CRDC ) today announced that Bernard A. Hausen, M.D., ... present a corporate overview and update at the following conferences: ... November 15, 2011 8:00 a.m. ET New York, NY ... 2011 9:30 a.m. New York, NY To access the ...
... 10, 2011 The Medical Oncology Association of ... recently signed an agreement to work together to ... quality and costs of cancer care in Southern ... clinical, reimbursement and distribution services to help health ...
Cached Medicine Technology:Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 2Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 3
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, ... with certain neuropsychiatric and chronic pain conditions, has announced appointments to three key ... include: Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior ...
(Date:6/29/2015)... ... , ... The world’s fastest and highest flying production aircraft, the SR-71 Blackbird, ... Virginia. This iconic, supersonic stealth plane will become the focal point of the Museum’s ... ceiling of a historic train station is perhaps one of the most unconventional presentations ...
(Date:6/29/2015)... ... June 29, 2015 , ... Celebrities have many skincare secrets, and skin ... all summer long and beyond. People don’t have to be famous to have ... process, maintain an even skin tone, avoid breakouts, and take skin health and wellness ...
(Date:6/29/2015)... PAUL, Minn. (PRWEB) , ... June 29, 2015 ... ... , an HVAC and plumbing company serving the Twin Cities area, provides money-saving ... overall energy efficiency strategies for Twin Cities’ residents, addressing water conservation and other ...
(Date:6/29/2015)... FL (PRWEB) , ... June 29, 2015 , ... Before launching the next product to ... products day in and day out. One simple question was asked: “What do you ... a pump. BPI used this information to create the next generation of pre-training powders ...
Breaking Medicine News(10 mins):Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:SR-71 Prepares for Flight to Science Museum of Virginia 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 3Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3Health News:The All-New PUMP HD™ by BPI Sports is Here to Energize Your Workouts 2
... Texas M. D. Anderson Cancer Center have found that ... growth factor expression are associated with poor survival in ... presented in a poster session today at the Society ... , Sex cord-stromal ovarian tumors are rare, accounting ...
... 5 Stephen H. Schneider, Ph.D.,professor of Environmental ... , a,climatologist and cancer survivor who shared the ... Gore, will be the keynote speaker at the ... FireSky Hotel in,Scottsdale. The conference attracts health care ...
... CINCINNATI, Feb. 5 LCA-Vision Inc. (Nasdaq: ... services under the Lasik Plus (R) brand, announces that ... Officer Michael J. Celebrezze will hold a conference call ... a.m. Eastern time to discuss management,s plan to drive ...
... Mich. --- Nearly 70 percent of minority women agree ... of the key findings of a Michigan State University ... breast cancer screenings. , The study of 341 Arab-American, ... of medical mistrust and assess the impact on whether ...
... Inc. (Pink Sheets: SYNJ) reports that it has engaged in ... the marketing campaign for the acquisition of and/or the start ... the "Director of Marketing" will be to coordinate and develop ... doctors, hospitals, and businesses in the specific location of each ...
... Tomorrow, millions of Americans will wear red to highlight ... as many women die from heart disease as breast cancer in ... primary care doctors still don,t know that heart attacks kill more ... women to continue wearing red once a week, to help sound ...
Cached Medicine News:Health News:Angiogenesis linked to poor survival in patients with rare type of ovarian cancer 2Health News:Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists 2Health News:Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists 3Health News:Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists 4Health News:LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6 2Health News:LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6 3Health News:MSU study finds high level of medical mistrust among minority women impacts quality of health care 2Health News:Syndication Inc. Seeks 'Director of Marketing' for 'Sy-Med Decompression Centers'; BOD Considers Adding a 'Green Energy' New Company Subsidiary to its Ranks 2Health News:'Go Red for Women' Gets Stronger by the Week 2
... has a graphical touch screen display which ... the "touch of a screen." Features ... Touch Screen, Graphical Display, Memory Cards, Gradient ... Format, Intuitive Programmin, Free Instrument Software Upgrade. ...
... compact design for personal use, yet is able to ... to 32 samples simultaneously. It contains a heating cover ... add mineral oil to prevent evaporation of the reaction ... up to 15 steps can be freely connected to ...
PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...
Px2 thermal Cycler chassis (requires block). Multiple interchangeable blocks. Gradient capability. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced r...
Medicine Products: